PROTEOGLYCANS IN NORMAL AND SCARRED CORNEAS
PROTEOGLYCANS IN NORMAL AND SCARRED CORNEAS
批准号:
2162980
负责人:
JAMES L FUNDERBURGH
金额:
$13.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-08-01 至 1998-07-31
关键词:
cell adhesion cell motility cellular pathology chondroitin sulfate B collagen connective tissue cells cornea corneal stroma extracellular matrix extracellular matrix proteins glycosylation high performance liquid chromatography histology human tissue keratan sulfate laboratory rabbit laminin macrophage protein sequence proteoglycan recombinant proteins scars transforming growth factors
中文摘要
角膜疤痕限制了全球数亿人的视力。
疤痕有多种病因,但通常是永久性的和可矫正的。
只能通过手术。这项研究的长期目标是确定
角膜瘢痕组织的物理、生物学特性及临床意义
控制其形成的条件。蛋白多糖构成了一种主要的
间质的成分和适当的蛋白多糖组成出现
对于角膜透明来说是必不可少的。有一个明显的变化,在
瘢痕组织与正常组织的蛋白多糖组成比较;
然而,疤痕蛋白多糖的性质还没有很好的定义。模特是
提出了蛋白多糖在瘢痕组织生物学中的作用
基于我们目前对细胞外基质生物学的了解。
对基于该模型的假设进行测试的实验旨在
完成四个具体目标:(1)比较正常和正常的蛋白多糖
在蛋白多糖分子类型方面,人的角膜有疤痕。(2)界定
角膜蛋白多糖与其他生化物质的特异性相互作用
角膜细胞外基质的成分。(3)检验生物
蛋白多糖的活性(4)决定调节瘢痕组织的因素
由角质形成细胞合成。对于第一个目的,抗体将被用来
确定蛋白多糖蛋白核心的丰度和同一性
组织切片和伤痕累累的人角膜提取液中。凝集素
而针对这些分子碳水化合物部分的抗体将
用来定义它们的糖基化状态。在目标2和3中,纯净
蛋白多糖,代表那些在疤痕和正常中被鉴定的
间质,将被检查与细胞外的特定相互作用
基质分子和瘢痕组织细胞。的状态的影响
核心蛋白中特定氨基酸序列的糖基化
通过使用脱糖蛋白和重组蛋白进行评估
含有部分核心蛋白质的。我们将研究互动
胶原蛋白、层粘连蛋白、转化生长因子β、角质形成细胞和
巨噬细胞,评估蛋白多糖结合及其生物学效应
装订。在第四个目标中,一种影响角质形成细胞的可溶性因素
功能将被提纯和表征。这些实验将
为我们理解角膜疤痕生物学提供必要的知识
以及我们控制这一病理过程的能力。
英文摘要
Corneal scars limit vision for hundreds of millions of persons worldwide.
Scarring has a diverse etiology but is usually permanent and correctable
only by surgery. The long-range goal of this research to determine the
physical and biological properties of corneal scar tissue and the
conditions that control its formation. Proteoglycans constitute a major
component of the stroma and proper proteoglycan composition appears
essential for corneal transparency. There is a marked alteration in the
proteoglycan composition of scar tissue compared to that of normal tissue;
however, the nature of scar proteoglycans is not well defined. A model is
presented proposing roles for proteoglycans in the biology of scar tissue
based on our current knowledge of extracellular matrix biology.
Experiments, testing hypotheses based on this model, are designed to
accomplish four specific aims: (1) Compare proteoglycans of normal and
scarred human corneas in terms of proteoglycan molecular types. (2) Define
specific interactions between corneal proteoglycans and other biochemical
components of the corneal extracellular matrix. (3) Examine the biological
activity of proteoglycans (4) Determine factors regulating scar tissue
synthesis by keratocytes. For the first aim, antibodies will be used to
determine the abundance and identity of proteoglycan protein cores in
histological sections and in extracts of scarred human corneas. Lectins
and antibodies against the carbohydrate portions of these molecules will
be used to define their state of glycosylation. In aim 2 & 3, purified
proteoglycans, representative of those identified in scarred and normal
stroma, will be examined for specific interactions with extracellular
matrix molecules and with cells of scar tissue. Effect of the state of
glycosylation and of specific amino acid sequence in the core protein will
be assessed by use of deglycosylated proteins and of recombinant-proteins
containing portions of the core proteins. Interactions will be examined
with collagens, laminin, transforming growth factor beta, keratocytes, and
macrophages, assessing proteoglycan binding and the biological effects of
the binding. In the fourth aim, a soluble factor affecting keratocyte
function will be purified and characterized. These experiments will
provide knowledge essential to our understanding of corneal scar biology
and to our ability to control this pathological process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioengineering Cornea with Autologous Stem Cells
-
批准号:9113712
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2016
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
A Pluripotent Stem Cell Reagent for Corneal Regeneration
-
批准号:8626779
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2013
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
A Pluripotent Stem Cell Reagent for Corneal Regeneration
-
批准号:8776715
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2013
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7221869
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7101389
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:9212811
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:8655870
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7613878
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7394345
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:8103366
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:8245697
-
项目类别:
-
资助金额:$44.52万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:8450197
-
项目类别:
-
资助金额:$42.29万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7796625
-
项目类别:
-
资助金额:$30.59万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Stem Cells for Corneal Engineering
-
批准号:7587273
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2006
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
CORE--MORPHOLOGY
-
批准号:6990104
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2004
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Acellular Tissue Matrix for Bioprosthetic Corneas
-
批准号:6725478
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2003
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Acellular Tissue Matrix for Bioprosthetic Corneas
-
批准号:6630180
-
项目类别:
-
资助金额:$15.36万
-
财政年份:2003
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Acellular Tissue Matrix for Bioprosthetic Corneas
-
批准号:6864414
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2003
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Tissue Culture and Histology Core
-
批准号:10394407
-
项目类别:
-
资助金额:$11.65万
-
财政年份:1997
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
Tissue Culture and Histology Core
-
批准号:10597627
-
项目类别:
-
资助金额:$10.93万
-
财政年份:1997
-
负责人:JAMES L FUNDERBURGH
-
依托单位:
海外基金